Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Essential Fatty acids - a review.

Undurti N Das1

  • 1UND Life Sciences, 13800 Fairhill Road, Shaker Heights, OH 44120, USA. undurti@hotmail.com

Current Pharmaceutical Biotechnology
|December 16, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Lipoxin A 4 (LXA 4 ) for diabetic retinopathy (DR).

Indian journal of ophthalmology·2026
Same author

Effect of essential fatty acids (EFAs) and their metabolites on the growth suppressive action of anti-cancer drug doxorubicin on neuro- and glioblastoma cells in vitro.

Prostaglandins & other lipid mediators·2026
Same author

Arachidonic Acid and Lipoxin A4 Protect Pancreatic β-Cells and Improve Hyperglycemia Induced by Bleomycin.

Journal of biochemical and molecular toxicology·2026
Same author

Is Sepsis an Essential Fatty Acids Deficiency State?

Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine·2025
Same author

Why vitamin C and corticosteroids are inadequate and how essential fatty acids (EFAs) can augment recovery from sepsis.

Nutrition (Burbank, Los Angeles County, Calif.)·2025
Same author

Arachidonic Acid Protects Skeletal Muscle Against Hyperglycaemia-Induced Muscle Atrophy by Modulating Myogenesis and Regulating KLF15 Expression in C57Bl/6 Mice.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology·2025
Same journal

Therapeutic Applications and Advancements of Exosome-Based Treatments - A Comprehensive Review.

Current pharmaceutical biotechnology·2026
Same journal

Comparative Phytochemical Characterization and Antibacterial Activity of Ethanol and Aqueous Extracts of Moringa peregrina and Moringa oleifera against Multidrug-Resistant Bacteria.

Current pharmaceutical biotechnology·2026
Same journal

Unveiling Aptamers for Targeted Tumour Therapies and Detection: Systematic Evolution of Ligands by Exponential Enrichment (SELEX) Technology in Oncology.

Current pharmaceutical biotechnology·2026
Same journal

Nanosuspensions-Based Dry Powder Inhalers for Pulmonary Delivery of Hydrophobic Natural Products: Formulation Strategies, Efficacy, and Challenges.

Current pharmaceutical biotechnology·2026
Same journal

Bone Marrow Mesenchymal Stem Cell-Derived Exosomes Accelerate Diabetic Rat Wound Healing by Inhibiting Pyroptosis through the NLRP3/Caspase-1/GSDMD Pathway.

Current pharmaceutical biotechnology·2026
Same journal

Cyperotundone Regulates Polo-like Kinase 1-mediated Glycolysis to Inhibit the Proliferation of Breast Cancer Cells.

Current pharmaceutical biotechnology·2026
See all related articles

Essential fatty acids (EFAs), vital for health, are metabolized into compounds that influence numerous bodily functions. Altered EFA metabolism is linked to various diseases, highlighting their clinical significance.

Area of Science:

  • Biochemistry
  • Human Physiology
  • Nutritional Science

Background:

  • Essential fatty acids (EFAs), namely cis-linoleic acid (LA) and alpha-linolenic acid (ALA), are crucial for human health and readily available in diets.
  • EFAs are precursors to vital long-chain metabolites like arachidonic acid (AA), eicosapentaenoic acid (EPA), and docosahexaenoic acid (DHA).
  • These metabolites are further transformed into prostaglandins, thromboxanes, leukotrienes, and resolvins, which are key signaling molecules.

Purpose of the Study:

  • To explore the metabolic pathways of EFAs and their derivatives.
  • To investigate the potential therapeutic roles of EFAs and their metabolites.
  • To understand the implications of altered EFA metabolism in various disease states.

Main Methods:

  • Literature review of EFA metabolism and function.

Related Experiment Videos

  • Analysis of the biochemical transformations of LA and ALA.
  • Examination of the signaling pathways involving EFA derivatives and their targets.

    • Main Results:

    • EFAs and metabolites exhibit potential roles as endogenous inhibitors of angiotensin converting enzyme and HMG-CoA reductase.
    • They can enhance nitric oxide (NO) production, acting as anti-hypertensive and anti-atherosclerotic agents.
    • EFAs react with NO to form nitroalkenes, activating peroxisome proliferator-activated receptors (PPARs) for cell signaling.

    Conclusions:

    • Altered EFA metabolism is associated with diseases including obesity, hypertension, diabetes, cardiovascular disease, and neurodegenerative disorders.
    • EFAs and their derivatives possess significant therapeutic potential due to their diverse biological activities.
    • Understanding EFA metabolism is crucial for developing novel treatment strategies for a range of chronic conditions.